Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:
“Pleased with the NCCN guidelines for Papillary only disease in non-muscle invasive bladder cancer (NMIBC). Validates the publication in Journal of Urology. Now next step is to provide BCG for all patients who could benefit in bladder cancer.”
Title: Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer
Authors: Sam S Chang, Karim Chamie, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal, Jeffrey C Bassett, Marc Bjurlin, Michael L Cher, William Clark, Barrett E Cowan, Richard David, Evan Goldfischer, Khurshid Guru, Mark W Jalkut, Samuel D Kaffenberger, Jed Kaminetsky, Anthony Corcoran, Alec S Koo, Wade J Sexton, Sergei N Tikhonenkov, Mihir S Shah, Edouard J Trabulsi, Andrew F Trainer, Patricia Spilman, Megan Huang, Paul Bhar, Leylah M Drusbosky, Lennie Sender, Bruce Brown, Sandeep Reddy, Patrick Soon-Shiong
Read the full article on PubMed.
Other articles about Patrick Soon-Shiong on OncoDaily,